Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201404139 Principal Investigator: Adkins, Douglas
Title: Phase I/II Trial of the Addition of PD 0332991 to Cetuximab in Patients with Incurable SCCHN
Phase: I/II Disease Site: Lip, Oral Cavity and Pharynx
Participating Site(s):
 
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to find the maximum tolerated dose of a drug called palbociclib when given in combination with a drug called cetuximab, and to evaluate the side effects of this combination and look at how effective it is.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)